Search Results - "Ketterling, Rhett P"

MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis by Tefferi, Ayalew, Guglielmelli, Paola, Lasho, Terra L, Gangat, Naseema, Ketterling, Rhett P, Pardanani, Animesh, Vannucchi, Alessandro M

Get full text

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis by Tefferi, Ayalew, Guglielmelli, Paola, Larson, Dirk R., Finke, Christy, Wassie, Emnet A., Pieri, Lisa, Gangat, Naseema, Fjerza, Rajmonda, Belachew, Alem A., Lasho, Terra L., Ketterling, Rhett P., Hanson, Curtis A., Rambaldi, Alessandro, Finazzi, Guido, Thiele, Juergen, Barbui, Tiziano, Pardanani, Animesh, Vannucchi, Alessandro M.

“…Janus kinase 2 (JAK2) mutations define polycythemia vera (PV). Calreticulin (CALR) and myeloproliferative leukemia virus oncogene (MPL) mutations are specific…”
Get full text

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis by Tefferi, Ayalew, Guglielmelli, Paola, Nicolosi, Maura, Mannelli, Francesco, Mudireddy, Mythri, Bartalucci, Niccolo, Finke, Christy M., Lasho, Terra L., Hanson, Curtis A., Ketterling, Rhett P., Begna, Kebede H., Naseema Gangat, Pardanani, Animesh, Vannucchi, Alessandro M.

“…International collaborations over the years have produced a series of prognostic models for primary myelofibrosis (PMF), including the recently unveiled…”
Get full text

Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients by Tefferi, Ayalew, Nicolosi, Maura, Mudireddy, Mythri, Lasho, Terra L., Gangat, Naseema, Begna, Kebede H., Hanson, Curtis A., Ketterling, Rhett P., Pardanani, Animesh

“…Current cytogenetic risk stratification in primary myelofibrosis (PMF) is two-tiered: ‘favorable’ and ‘unfavorable’. Recent studies have suggested prognostic…”
Get full text

U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions by Tefferi, Ayalew, Finke, Christy M., Lasho, Terra L., Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema, Pardanani, Animesh

Get full text

Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma by Feldman, Andrew L., Oishi, Naoki, Ketterling, Rhett P., Ansell, Stephen M., Shi, Min, Dasari, Surendra

“…Anaplastic large cell lymphoma (ALCL) can be classified genetically based on rearrangements (R) of the ALK , TP63 , and/or DUSP22 genes. ALK- R defines a…”
Get full text

Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts by Tefferi, Ayalew, Mudireddy, Mythri, Mannelli, Francesco, Begna, Kebede H., Patnaik, Mrinal M., Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema, Yogarajah, Meera, De Stefano, Valerio, Passamonti, Francesco, Rosti, Vittorio, Finazzi, Maria Chiara, Rambaldi, Alessandro, Bosi, Alberto, Guglielmelli, Paola, Pardanani, Animesh, Vannucchi, Alessandro M.

“…A total of 410 patients with blast phase myeloproliferative neoplasm (MPN-BP) were retrospectively reviewed: 248 from the Mayo Clinic and 162 from Italy…”
Get full text

DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study by Pedersen, Martin Bjerregård, Hamilton-Dutoit, Stephen Jacques, Bendix, Knud, Ketterling, Rhett P., Bedroske, Patrick P., Luoma, Ivy M., Sattler, Christopher A., Boddicker, Rebecca L., Bennani, N.Nora, Nørgaard, Peter, Møller, Michael Boe, Steiniche, Torben, d'Amore, Francesco, Feldman, Andrew L.

Get full text

Anthracycline Dose Intensification in Acute Myeloid Leukemia by Fernandez, Hugo F, Sun, Zhuoxin, Yao, Xiaopan, Litzow, Mark R, Luger, Selina M, Paietta, Elisabeth M, Racevskis, Janis, Dewald, Gordon W, Ketterling, Rhett P, Bennett, John M, Rowe, Jacob M, Lazarus, Hillard M, Tallman, Martin S

“…Patients with AML who were between 17 and 60 years of age were randomly assigned to receive induction therapy with the standard dose of daunorubicin or twice…”
Get full text

Genetic subtyping of breast implant–associated anaplastic large cell lymphoma by Oishi, Naoki, Brody, Garry S., Ketterling, Rhett P., Viswanatha, David S., He, Rong, Dasari, Surendra, Mai, Ming, Benson, Hailey K., Sattler, Christopher A., Boddicker, Rebecca L., McPhail, Ellen D., Bennani, N. Nora, Harless, Christin A., Singh, Kuldeep, Clemens, Mark W., Medeiros, L. Jeffrey, Miranda, Roberto N., Feldman, Andrew L.

Get full text

Driver mutations and prognosis in primary myelofibrosis: Mayo‐Careggi MPN alliance study of 1,095 patients by Tefferi, Ayalew, Nicolosi, Maura, Mudireddy, Mythri, Szuber, Natasha, Finke, Christy M., Lasho, Terra L., Hanson, Curtis A., Ketterling, Rhett P., Pardanani, Animesh, Gangat, Naseema, Mannarelli, Carmela, Fanelli, Tiziana, Guglielmelli, Paola, Vannucchi, Alessandro M.

“…The 2013 discovery of calreticulin (CALR) mutations in myeloproliferative neoplasms was attended by their association with longer survival in primary…”
Get full text

Sex and degree of severity influence the prognostic impact of anemia in primary myelofibrosis: analysis based on 1109 consecutive patients by Nicolosi, Maura, Mudireddy, Mythri, Lasho, Terra L., Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema, Pardanani, Animesh, Tefferi, Ayalew

Get full text

Chromosomal Rearrangements of 6p25.3 Define a New Subtype of Lymphomatoid Papulosis by Karai, Laszlo J, Kadin, Marshall E, Hsi, Eric D, Sluzevich, Jason C, Ketterling, Rhett P, Knudson, Ryan A, Feldman, Andrew L

“…Lymphomatoid papulosis (LyP) is an indolent cutaneous lymphoproliferative disorder with clinical and pathologic features overlapping those of both reactive…”
Get full text

Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma by Ravindran, Aishwarya, Feldman, Andrew L., Ketterling, Rhett P., Dasari, Surendra, Rech, Karen L., McPhail, Ellen D., Kurtin, Paul J., Shi, Min

“…Anaplastic large cell lymphomas (ALCLs) are broadly classified into ALK-positive and ALK-negative. ALK-negative ALCL is composed of DUSP22-rearranged,…”
Get full text

RNAseq identification of FISH‐cryptic BCL6::TP63 rearrangement in ALK‐negative anaplastic large‐cell lymphoma by Ahmed, Nada, Ketterling, Rhett P, Nowakowski, Grzegorz S, Dasari, Surendra, Feldman, Andrew L

Get full text

Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups by Luskin, Marlise R., Lee, Ju-Whei, Fernandez, Hugo F., Abdel-Wahab, Omar, Bennett, John M., Ketterling, Rhett P., Lazarus, Hillard M., Levine, Ross L., Litzow, Mark R., Paietta, Elisabeth M., Patel, Jay P., Racevskis, Janis, Rowe, Jacob M., Tallman, Martin S., Sun, Zhuoxin, Luger, Selina M.

“…The initial report of the Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group trial E1900 (#NCT00049517)…”
Get full text

Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients by Tefferi, Ayalew, Wassie, Emnet A., Guglielmelli, Paola, Gangat, Naseema, Belachew, Alem A., Lasho, Terra L., Finke, Christy, Ketterling, Rhett P., Hanson, Curtis A., Pardanani, Animesh, Wolanskyj, Alexandra P., Maffioli, Margherita, Casalone, Rosario, Pacilli, Annalisa, Vannucchi, Alessandro M., Passamonti, Francesco

“…CALR (calreticulin) trails JAK2 as the second most mutated gene in essential thrombocythemia (ET). Mutant CALR in ET is a result of frameshift mutations,…”
Get full text

Targeted next‐generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS‐R by Tefferi, Ayalew, Lasho, Terra L., Patnaik, Mrinal M., Saeed, Lyla, Mudireddy, Mythri, Idossa, Dame, Finke, Christy, Ketterling, Rhett P., Pardanani, Animesh, Gangat, Naseema

“…A 27‐gene panel was used for next‐generation sequencing (NGS) in 179 patients (median age 73 years) with primary myelodysplastic syndromes (MDS); risk…”
Get full text

Targeted deep sequencing in primary myelofibrosis by Tefferi, Ayalew, Lasho, Terra L., Finke, Christy M., Elala, Yoseph, Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema, Pardanani, Animesh

“…A myeloid neoplasm–relevant 27-gene panel was used for next-generation sequencing of bone marrow or whole blood DNA in 182 patients with primary myelofibrosis…”
Get full text

Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia by Patnaik, Mrinal M., Barraco, Daniela, Lasho, Terra L., Finke, Christy M., Reichard, Kaaren, Hoversten, Katherine P., Ketterling, Rhett P., Gangat, Naseema, Tefferi, Ayalew

“…Atypical chronic myeloid leukemia (aCML) is an aggressive myeloid neoplasm with overlapping features of myelodysplastic syndromes (prominent granulocytic…”
Get full text